NAD+ and NMN: the science of cellular energy and aging

What is NAD+?

NAD+ stands for nicotinamide adenine dinucleotide — one of the most important coenzymes in the body. It is present in every cell and involved in hundreds of reactions. Think of it as a shuttle that carries electrons between reactions. Without NAD+, cells can't produce energy from food, DNA repair mechanisms don't work, and signaling systems break down.

There are two forms: NAD+ (oxidized, electron-accepting) and NADH (reduced, electron-donating). The NAD+/NADH ratio is a critical metabolic marker — a low ratio indicates an energy-depleted state.

Why NAD+ declines with age

NAD+ levels decline with age across species. By some estimates, NAD+ levels around age 50 may be roughly half those at age 20 — though this varies by tissue and is not fully settled. NAD+ is required for:

• Mitochondrial energy production — the electron carrier in glycolysis, the Krebs/TCA cycle, and the electron transport chain. When NAD+ declines, ATP production drops.
• DNA repair — a co-substrate for PARP (poly ADP-ribose polymerase) enzymes, and involved in sirtuin activity. When NAD+ declines, DNA damage accumulates.
• Sirtuin activity — sirtuins (SIRT1–SIRT7) regulate DNA repair, inflammation, mitochondrial function, cell survival, and metabolic gene expression. They require NAD+, and are sometimes called "longevity proteins."
• Cellular signaling — calcium signaling, immune cell function, and circadian rhythm.

What causes NAD+ decline?

• Increased consumption — NAD+ is consumed by PARPs (activated by DNA damage), sirtuins, and CD38/CD157 ectoenzymes. DNA damage and inflammation accelerate consumption, creating a vicious cycle.
• Decreased synthesis — reduced activity of salvage-pathway enzymes (NAMPT, NMNAT), and reduced tryptophan availability.
• Metabolic competition — high NADH (poor metabolic health) shifts the equilibrium away from NAD+.

NAD+ precursors: how do you raise NAD+?

NMN (nicotinamide mononucleotide)

One of the most researched precursors, converted to NAD+ through enzymatic reactions.

How it works. NMN is reported to be imported into cells by a transporter called Slc12a8 (a finding that has been debated), then converted to NAD+ by NMNAT.

Evidence. NMN raises NAD+ in multiple tissues in aged mice, improves mitochondrial function, and extends lifespan in some mouse models of accelerated aging, with multiple human trials completed or ongoing.

Human NMN trials. A frequently cited trial — Igarashi et al., published in npj Aging (2022) — was a 12-week study giving 250 mg/day to healthy men aged 65 and older. It raised blood NAD+ and improved gait (walking) speed and grip strength. A separate study — Yoshino et al., published in Science (2021) — found that roughly 10 weeks of NMN improved skeletal-muscle insulin sensitivity in postmenopausal women with prediabetes. Promising but early signals: the trials are small and short-term.

NR (nicotinamide riboside)

Another precursor — a form of vitamin B3 — converted to NMN then NAD+ through a different pathway than oral NMN.

Evidence. NR raises NAD+ in humans across multiple trials, with some evidence for improved cognitive function in older adults and improved metabolic markers in prediabetics. It is less well-studied than NMN for longevity outcomes, though it has been studied more extensively in humans than NMN. The David Sinclair lab at Harvard popularized both compounds, though they have different metabolic routes.

Nicotinamide (NAM) and niacin (B3)

Older, cheaper precursors. Niacin (nicotinic acid) raises NAD+ but is limited by a flushing side effect (prostaglandin-mediated vasodilation); high-dose niacin has been used clinically for decades for lipid management. Nicotinamide (NAM) also raises NAD+ and does not cause flushing — but it is a byproduct of NAD+ consumption that inhibits sirtuins and PARPs, creating a negative feedback loop. This is part of why NR and NMN may be superior strategies: they bypass this inhibition.

What the research actually shows

In animals. NMN and NR extend lifespan in some (not all) mouse studies, and improve mitochondrial function, insulin sensitivity, cognition, and blood vessel function in aged mice, with reduced DNA damage accumulation. The effects are substantial but not universal — lifespan extension isn't consistent across strains.

In humans. NAD+ levels are raised consistently. There is some evidence for improved physical performance, mixed evidence for insulin sensitivity, limited cognitive data, and no long-term healthspan or lifespan data.

What David Sinclair says — and the criticism

David Sinclair (Harvard Medical School) is one of the most prominent advocates for NAD+ and NMN, and his lab produced much of the foundational animal research. His central claim: NAD+ decline is a primary driver of aging, and restoring it can slow or reverse aging.

The criticism is real within the research community. Much of the most compelling data comes from accelerated-aging mouse models rather than normally aged mice; the mouse-to-human translation is uncertain; human trials have been small and short-term; and supplements are sold on the strength of far more compelling animal data than human data.

Sourcing and quality

• NMN — typically 250–500 mg/day in research protocols; oral; quality varies.
• NR — similar dosing, often combined with pterostilbene.
• Combination products — often include NMN, NR, resveratrol, and cofactors.
• Regulatory note — NMN is not approved as a supplement in some jurisdictions, creating a legal gray area.

The bottom line on NAD+

NAD+ decline with age is real and well-documented, and the mechanistic links to mitochondrial dysfunction, DNA damage, and sirtuin inactivation are biologically plausible and well-supported. NAD+ precursors (NMN, NR) reliably raise NAD+ in humans and animals, and early trials show some promising signals.

The honest summary: this is one of the more scientifically grounded longevity supplement strategies — stronger evidence than most — but not yet at the level of a proven anti-aging intervention.